Related references
Note: Only part of the references are listed.Construction of pancreas-muscle-liver microphysiological system (MPS) for reproducing glucose metabolism
Dong Wook Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips
Rachelle Prantil-Baun et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies
Seiichi Ishida
DRUG METABOLISM AND PHARMACOKINETICS (2018)
A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model
Hyuna Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
The ascendance of microphysiological systems to solve the drug testing dilemma
Eva-Maria Dehne et al.
FUTURE SCIENCE OA (2017)
Biology-Inspired Microphysiological System Approaches to Solve the Prediction Dilemma of Substance Testing
Uwe Marx et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2016)
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Meritxell Huch et al.
CELL (2015)
Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling
Hasan Erbil Abaci et al.
INTEGRATIVE BIOLOGY (2015)
Long-term culture and expansion of primary human hepatocytes
Gahl Levy et al.
NATURE BIOTECHNOLOGY (2015)
Organs-on-chips at the frontiers of drug discovery
Eric W. Esch et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
The effects of poly(dimethylsiloxane) surface silanization on the mesenchymal stem cell fate
Yon Jin Chuah et al.
BIOMATERIALS SCIENCE (2015)
Image-based evaluations of distribution and cytotoxicity of Irinotecan (CPT-11) in a multi-compartment micro-cell coculture device
Hidenari Nakayama et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2014)
Microfluidic organs-on-chips
Sangeeta N. Bhatia et al.
NATURE BIOTECHNOLOGY (2014)
Clinical implications of CES2 RNA expression in neuroblastoma
Keiichi Uchida et al.
JOURNAL OF PEDIATRIC SURGERY (2013)
Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
Chi C. Wong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug-drug interaction study
Jessica M. van der Bol et al.
EUROPEAN JOURNAL OF CANCER (2011)
Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives
Ramesh Mullangi et al.
BIOMEDICAL CHROMATOGRAPHY (2010)
In Vitro Evaluation of Inhibitory Effects of Antidiabetic and Antihyperlipidemic Drugs on Human Carboxylesterase Activities
Tatsuki Fukami et al.
DRUG METABOLISM AND DISPOSITION (2010)
A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip
Jong Hwan Sung et al.
LAB ON A CHIP (2010)
An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models
Hiroshi Kimura et al.
LAB ON A CHIP (2008)
Lopinavir-Ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma
G. Corona et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells
Walter M. A. Westerink et al.
TOXICOLOGY IN VITRO (2007)
The cardenolide UNBS1450 is able to deactivate nuclear factor κB-mediated cytoprotective effects in human non-small cell lung cancer cells
T Mijatovic et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Comparison of primary human hepatocytes and hepatoma cell line HEPG2 with regard to their biotransformation properties
S Wilkening et al.
DRUG METABOLISM AND DISPOSITION (2003)
Poly(dimethylsiloxane) as a material for fabricating microfluidic devices
JC McDonald et al.
ACCOUNTS OF CHEMICAL RESEARCH (2002)